Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nep… Read more
Torrent Pharmaceuticals Limited (TORNTPHARM) - Total Liabilities
Latest total liabilities as of September 2025: ₹70.66 Billion INR
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has total liabilities worth ₹70.66 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Torrent Pharmaceuticals Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Torrent Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Torrent Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ming Yang Smart Energy Group Ltd
SHG:601615
|
China | CN¥63.91 Billion |
|
Persimmon Plc
PINK:PSMMY
|
USA | $1.51 Billion |
|
Getlink SE
OTCGREY:GRPTF
|
USA | $6.35 Billion |
|
Mohawk Industries Inc
NYSE:MHK
|
USA | $5.31 Billion |
|
Granite Construction Incorporated
NYSE:GVA
|
USA | $2.81 Billion |
|
Nissan Motor Co. Ltd.
PINK:NSANF
|
USA | $14.38 Trillion |
|
Global Net Lease Inc. 7.50% Cum. Redeem. Pfd. Series D
NYSE:GNL-PD
|
USA | $3.06 Billion |
|
Allegro.eu SA
PINK:ALEGF
|
USA | $9.60 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Torrent Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.16 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Torrent Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Torrent Pharmaceuticals Limited (2005–2025)
The table below shows the annual total liabilities of Torrent Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹73.99 Billion | -9.82% |
| 2024-03-31 | ₹82.04 Billion | -6.92% |
| 2023-03-31 | ₹88.14 Billion | +23.33% |
| 2022-03-31 | ₹71.47 Billion | -13.24% |
| 2021-03-31 | ₹82.37 Billion | -10.60% |
| 2020-03-31 | ₹92.15 Billion | -1.94% |
| 2019-03-31 | ₹93.97 Billion | -2.33% |
| 2018-03-31 | ₹96.21 Billion | +66.61% |
| 2017-03-31 | ₹57.74 Billion | +2.67% |
| 2016-03-31 | ₹56.24 Billion | +3.76% |
| 2015-03-31 | ₹54.20 Billion | +71.14% |
| 2014-03-31 | ₹31.67 Billion | +34.16% |
| 2013-03-31 | ₹23.61 Billion | +25.81% |
| 2012-03-31 | ₹18.76 Billion | +23.08% |
| 2011-03-31 | ₹15.24 Billion | +34.41% |
| 2010-03-31 | ₹11.34 Billion | +11.57% |
| 2009-03-31 | ₹10.17 Billion | +34.42% |
| 2008-03-31 | ₹7.56 Billion | +19.15% |
| 2007-03-31 | ₹6.35 Billion | +6.84% |
| 2006-03-31 | ₹5.94 Billion | +50.36% |
| 2005-03-31 | ₹3.95 Billion | -- |